No abstract

Objectives: The objective of this study was to evaluate the performance of the Boditech i-CHROMA™ point-of-care testing (POCT) method for the quantification of serum CReactive Protein (CRP) and Urine Microalbumin (MAU) compared well with the traditional Abbott Architect Ci8200 laboratory method. Design and Methods:Serum samples of CRP (n=44) and urine samples for MAU estimation (n=25) were analysed at the Homerton University Hospital using the routine laboratory method (Abbott Architect Ci8200) and the Boditech i-CHROMA™ POCT method. Results:The i-CHROMA™ CRP and MAU method showed good correlation with that of the Abbott Architect Ci8200: r 2 =0.905 and r 2 =0.987 respectively. Overall, there was a slight negative bias seen with the i-CHROMA™ CRP method (bias=-8.15, bias difference=-9.05%) and a negative bias seen with the i-CHROMA™ MAU method (bias=35.84, bias difference=-27.88%). Conclusion:The Boditech i-CHROMA™ POCT method provide a reliable measurement of CRP and MAU and compared well with the traditional Abbott Architect Ci8200 laboratory method.

No abstract

This work is licensed under Creative Commons Attribution 4.0 License AJBSR.MS.ID.000859.

A survey was carried out on healthcare professionals in Nigeria on point of care testing in critical care. The respondents considered the glucose test as the most essential critical test followed by Full Blood Count (FBC), and then electrolytes, urea and creatinine. Blood gases ranked quite low with only 62% of the healthcare professionals considering them as a critical blood test. This was confirmed as it was found that only 31.6% of the respondents had blood gases devices in their institutions. Abbott's i-STAT was the most common POCT device used for blood gas estimation by 45% of the respondents, followed by Instrumentation Laboratories, 3500 and 4000 series (9.8%) and then by Roche's Cobas B221 (9%). From the features of blood gas devices which included price of analyser, price of cartridge, analysis time, portability, range of tests, power supply and volume of blood used, the price of analyser, was the product feature that respondents considered as most important. About one third of respondents ranked analysis time or range of tests possible as a priority specification, while about one quarter prioritised portability, price of cartridge or volume of blood needed. Power supply was the lowest ranking feature. dialysis and intensive care units, the average turn-around time